M4MM
BREAKING: Colorado Passes Landmark Ibogaine Research Bill, Expanding the State’s Natural Medicine Framework
DENVER- Colorado has taken another major step in the evolution of regulated psychedelic medicine. The Colorado legislature has passed House Bill 26-1325, a landmark measure that establishes an ibogaine research pilot program within the state’s ...
The DEA Window: The Real Fight Is Over Who Qualifies as Medical Cannabis
WASHINGTON, D.C. - The real significance of the DEA window is not that the Cannabis industry needs another explanation of legalization. Operators, investors, attorneys, and regulators already understand the limits of federal reform. The more ...
Study: Older Americans Are Turning to Cannabis as an Alternative to Pharmaceuticals
NEW YORK - Older Americans are increasingly looking at Cannabis not as a lifestyle product, but as a practical alternative to traditional pharmaceuticals. A new study highlighted by NORML points to a growing trend among ...
Israeli Cannabis Breakthrough Opens New Hope for Fatty Liver Disease
NEW YORK- A new study out of Israel has put Cannabis back into one of the most important conversations in modern medicine: metabolic disease. Researchers at the Hebrew University of Jerusalem have reported that two ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The ...
Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine
NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune ...
Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine
NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of ...
BREAKING: Colorado Passes Landmark Ibogaine Research Bill, Expanding the State’s Natural Medicine Framework
DENVER- Colorado has taken another major step in the evolution of regulated psychedelic medicine. The Colorado legislature has passed House Bill 26-1325, a landmark measure that establishes an ibogaine research pilot program within the state’s ...
The DEA Window: The Real Fight Is Over Who Qualifies as Medical Cannabis
WASHINGTON, D.C. - The real significance of the DEA window is not that the Cannabis industry needs another explanation of legalization. Operators, investors, attorneys, and regulators already understand the limits of federal reform. The more ...
Study: Older Americans Are Turning to Cannabis as an Alternative to Pharmaceuticals
NEW YORK - Older Americans are increasingly looking at Cannabis not as a lifestyle product, but as a practical alternative to traditional pharmaceuticals. A new study highlighted by NORML points to a growing trend among ...
Explosion at New Jersey Extraction Facility Highlights Ongoing Safety Risks in Cannabis Processing
NEW JERSEY–A powerful explosion at an extraction facility in Logan Township, New Jersey on March 4 has left several workers seriously injured and reignited discussion around safety risks in solvent-based Cannabis processing. The blast occurred ...
Cresco Labs Reports Q4 and Fiscal Year 2025 Financial Results
CHICAGO – Cresco Labs Inc. released its fourth-quarter and full-year 2025 earnings, showing revenue of $162 million for the final three months and a focus on cash flow amid industry pressures. The company generated $656 ...
Alabama Gears Up for Medical Cannabis Launch in April
MONTGOMERY – After years of legal hurdles and regulatory delays, Alabama's medical Cannabis program appears on track for an April start, with dispensaries poised to open doors to qualified patients. The Alabama Medical Cannabis Commission ...
Aurora Ditches Adult-Use Cannabis Market for Medical Focus
EDMONTON – Aurora Cannabis Inc. has completed its transition away from Canada's adult-use market to concentrate fully on medical Cannabis, targeting more profitable regulated opportunities overseas. Chief Financial Officer Simona King revealed the strategy during ...
Connecticut Lawmakers Expand Psychedelics Access
HARTFORD – Connecticut's Joint Committee on Public Health approved a bill that broadens the state's pilot program for psychedelic-assisted therapy, opening it to adults beyond just veterans and first responders. The measure, Senate Bill 191, ...
RYTHM Reports Q4 and FY 2025 Financial Results
ROLLING MEADOWS – RYTHM Inc. delivered a significant revenue leap in 2025, fueled by licensing deals in the fast-growing low-dose Cannabis alternatives market. Full-year sales hit $17.3 million, yet the company posted a $33.3 million ...
California Collected $255M in Q4 Cannabis Tax Revenue
SACRAMENTO – California collected $255.1 million in Cannabis tax revenue during the fourth quarter of 2025, marking a decline from the previous quarter as sales softened and a short-term tax adjustment ended. The total includes ...
Los Angeles City Council Advances a Tax Amnesty Program for Licensed Cannabis Businesses
LOS ANGELES – The City Council voted 13-0 to instruct staff to craft a tax amnesty program for more than 500 licensed Cannabis businesses that collectively owe approximately $400 million in back taxes, penalties, and ...
REVIEW: CannBev Summit-Recap from Brandon Bobart
MIAMI - The CannaBev Summit in Miami Beach took place at a pivotal moment for the hemp-derived THC beverage industry. The uncertainty referenced throughout the event is regulatory and political. Specifically, it centers on whether ...
What’s it Like Being a Black Entrepreneur in Cannabis?
COLUMBUS, OHIO- Although I was born and raised in Cleveland, my journey as a black entrepreneur in Cannabis didn’t start in a dispensary or at a grow facility. It actually started in culture, in music. ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – It's been another fortnight, and the numbers, the deals, and the science keep telling the same story: the Cannabis & Psychedelics space is not slowing down. A few from the MSOs pack ...
Trulieve Reports Q4 and FY 2025 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp., the largest U.S. Cannabis retailer by store count, announced its full-year 2025 revenue of $1.2 billion, holding steady from the previous year as retail pricing pressures offset gains from new ...
Curaleaf Reports Q4 and FY 2025 Financial Results
NEW YORK – Curaleaf Holdings Inc. released its earnings for the fourth quarter and full year ended December 31, 2025, highlighting a return to top-line growth and steady margins in a tough domestic environment. The ...
DOJ Urges SCOTUS to Ban Cannabis Consumers from Owning Guns
WASHINGTON, D.C. –The U.S. Department of Justice is strongly urging the Supreme Court to uphold a federal rule that bars Cannabis consumers from legally owning or purchasing firearms. In a brief filed with the Court, ...
GTI Reports Q4 and FY 2025 Financial Results
CHICAGO – Green Thumb Industries Inc. released its fourth-quarter and full-year 2025 earnings, showing revenue growth that outpaced the prior period even as pricing pressures continued to squeeze profitability metrics across its operations. The Chicago-based ...
